key: cord-0822997-sf1iruul authors: Wang, C.; Li, X.; Ning, W.; Gong, S.; Yang, F.; Fang, C.; Gong, Y.; Wu, D.; Huang, M.; Gou, Y.; Fu, S.; Ren, Y.; Yang, R.; Qiu, Y.; Xue, Y.; Xu, Y.; Zhou, X. title: Multi-Omic Profiling of Plasma Identify Biomarkers and Pathogenesis of COVID-19 in Children date: 2021-03-06 journal: nan DOI: 10.1101/2021.03.04.21252876 sha: 20a702b90b66e57f40d5525dd1b2efd33cf92835 doc_id: 822997 cord_uid: sf1iruul Although children usually develop less severe disease responding to COVID-19 than adults, little is known about the pathogenesis of COVID-19 in children. Herein, we conducted the plasma proteomic and metabolomic profiling of a cohort of COVID-19 pediatric patients with mild symptoms. Our data show that numerous proteins and metabolites involved in immune as well as anti-inflammatory processes were up-regulated on a larger scale in children than in adults. By developing a machine learning-based pipeline, we prioritized two sets of biomarker combinations, and identified 5 proteins and 5 metabolites as potential children-specific COVID-19 biomarkers. Further study showed that these identified metabolites not only inhibited the expression of pro-inflammatory factors, but also suppressed coronaviral replication, implying that these factors played key roles in protecting pediatric patients from both viral infection and infection-induced inflammation. Together, our study uncovered a protective mechanism responding to COVID-19 in children, and sheds light on potential therapies. The pandemic of Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory 44 syndrome coronavirus 2 (SARS-CoV-2) has become the worst public health crisis once a century, 45 which has caused over 97 million human infections and 2 million deaths all over the world. It had 46 been found that all people are susceptible to SARS-CoV-2 without significant differences in sex or 47 age 1-3 , and SARS-CoV-2 infects children under 18-year-old at a similar rate as adults 4 . Reports 48 from different countries showed that the symptoms are milder in the overwhelming majority of 49 children with COVID-19 (CC) compared to that of adults with COVID-19 (AC) 1-3, 5-11 . Most children 50 have minor symptoms or an asymptomatic SARSCoV2 infection and severe conditions such as 51 acute respiratory distress syndrome and multisystem inflammatory syndrome are rare in CC [12] [13] [14] . 52 Several theories have been discussed to explain the differences in clinical symptoms between 53 CC and AC 15 . One possible theory is the differences in the composition and functional 54 responsiveness of immune systems between children and adults 16 . Children have a qualitatively 55 different response to SARS-CoV-2 compared to adults 17 . Besides, young children were usually 56 4 / 33 For each blood sample, plasma was separated, and total proteins were extracted, denatured and 91 digested into peptides by trypsin (Fig. 1A) . Then, the 30 plasma samples were separated into 2 92 batches and individually subjected to tandem mass tag (TMT) labeling (Table S2) . For each batch, 93 individual samples were labeled with TMT 16-plex reagents, and a pooling mixture of all the 30 94 samples was included and labeled as a standard control to eliminate the batch effect. After 95 fractionation, each batch of peptide mixtures was analyzed by liquid chromatography with tandem 96 mass spectrometry (LC-MS/MS). The hydrophilic and hydrophobic metabolites were extracted 97 from each plasma sample, respectively and then determined via using liquid chromatography 98 electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) system. The identification of 99 metabolites was conducted by using home-made database with retention time and ion pairs or 100 searching against the public databases based on MS/MS spectra for those metabolites without 101 authentic standards in our database. 102 Recently, we conducted metabolomic and proteomic profilings of plasma samples from adults 103 with or without SARS-CoV-2 infection, and identified numerous molecular alterations associated 104 with COVID-19 in adults 20, 21 . From our two previous studies, we obtained the TMT-based 105 quantitative proteomic data of 43 AC cases and 13 healthy adults (HA), and metabolomic data of 106 34 AC and 10 HA cases. In total, there were 1033 proteins and 1129 metabolites quantified from 107 AC and HA cases. 23 . We found that 757 proteins were quantified in at least one sample (Table S3) , 114 with average numbers of 666 and 666 proteins in the 18 CC and 12 HC samples, respectively (Fig. 115 S1B). We checked the raw MS/MS data and found that 4877 peptides (48.4%) could be matched 116 by ≥ 2 spectral counts (Fig. S1C) . The average spectral counts were calculated as 2.6 for all peptides, 117 indicating a high quality of peptide identification. Also, we found that 626 proteins (79.2%) could 118 be traced and supported by ≥ 2 peptides, with an average number of 11.1 peptides (Fig. S1D) . Thus, 119 our proteomic data was also highly reliable at the protein level. After the metabolomic profiling, 120 from the principal component analysis (PCA) results, it was found that the 4 QC samples can be 121 clustered in the center, indicating a high quality of metabolomic identification (Fig. S1E) . We in 122 total obtained 1174 metabolites from the 30 samples (Table S4) , with an average number of 1140.7 123 metabolites per sample (Fig. S1F) . The multiquant software package was used for quantification. From the multi-omic profiling, the intensity-based abundances (IBAs) of proteins and 125 metabolites were obtained. For each batch of the proteomic data, the relative protein abundances 126 (RPA) were obtained by normalizing the control sample, and proteins not quantified in control were 127 discarded. To ensure the data quality, only 575 proteins and 1158 metabolites mutually quantified 128 in > 80% samples for further analysis, and a heatmap was illustrated after a hierarchical clustering 129 (Fig. S2 ). It could be found that CC and HC cases have distinct molecular signatures. For each 130 protein or metabolites, normal distribution imputation (NI) was applied to impute the missing 131 values 24 . To measure the variability of proteomic and metabolomic quantification, the coefficient 132 of variation (CV) was calculated for each molecule, with median values of 0.172 and 0.135 for the 133 proteomic data, and 0.122 and 0.122 for the metabolomic data in CC and HC samples, respectively 134 (Fig. 1B) . The low CV values supported a high reproducibility of the multi-omic quantification. 135 Then, the principal component analysis (PCA) was conducted for the proteomic (Fig. 1C ) and 136 metabolomic data (Fig. 1D) . From the results, it was found that CC and HC cases could be clearly 137 distinguished using either the data type, indicating molecular alterations were quite significant in 138 both omic levels. In addition, we calculated the average Pearson correlation coefficient (PCC) for 139 each pair of samples using the proteomic (Fig. 1E ) or metabolomic data (Fig. 1F) , and the results 140 supported that similar molecular alterations triggered in CC cases. Table S5-S6) . However, up-regulated molecules exhibited stronger changes in expression, 149 supporting that COVID-19-associated molecular alterations are not mild in children. 150 To further identify molecular alterations in CC against AC cases, the intrinsic differences 151 between adults and children were eliminated by calculating normalized abundance values (NAVs) 152 of proteins and metabolites in CC or AC cases against their counterparts in HC or HA samples. 153 Again, 332 proteins and 783 metabolites simultaneously quantified in > 80% children and adults 154 were reserved to ensure the data quality, and the PCA analysis demonstrated that CC and AC 155 samples can be clearly distinguished either by the proteomic or metabolomic data ( Fig. S3A-B) . 156 Using NAVs, we identified 196 DEPs and 449 DEMs in CC against HC cases ( Fig. 2C -D, 6 / 33 regulated in CC cases, whereas up-regulated metabolites exhibited stronger changes in expression. 159 This result not only support some strong molecular alterations in CC cases, but also suggested that 160 different biological and metabolic processes are affected upon COVID-19 in CC against AC cases. 161 Next, we used the annotations of Gene Ontology (GO) biological processes and Kyoto 162 Encyclopedia of Genes and Genomes (KEGG) pathways, and performed functional enrichment 163 analyses for proteins and metabolites, respectively (Fig. 2E-F and Table S9 -S10). We found that a confirmed that COVID-19-associated molecular alterations occurred in CC cases, as did in AC 172 cases. 173 We sought to examine the CC-specific molecules by overlapping DEPs and DEMs of CC vs. 174 HC and CC vs AS, and identified 44 and 249 CC-specific DEPs and DEMs, respectively (Fig. 2G-175 H and Table S11 -S12). We performed functional enrichment analyses for CC-specific DEPs ( and we also computed the total root mean squared error (RMSE) to measure the prediction bias. In 193 the step of FCP, a widely used machine learning algorithm, penalized logistic regression (PLR) 25-27 , 194 was used for model training and parameter optimization (Fig. 3A) . The CC-specific biomarker 195 combinations were separately determined for the proteomic and metabolic data. 196 From the results, there were 8098 protein combinations and 8376 metabolite combinations 197 with a total AUC value of 1 (Table S13-S14), indicating that too many combinations could achieve 198 a perfect accuracy on the existing data. However, a minimal RMSE value between predicted scores 199 and observed values will ensure the robustness and reliability of the model on the new data. With Table S15 ). Although individual molecules can reach a perfect accuracy on the current data, the 213 combination of multiple molecules was undoubtedly important to reduce the prediction bias. (Table S11 ). Thus, the remarkably alternations of coagulation-related proteins in CC plasma suggest that 227 COVID-19-associated coagulation and the accompanying immune response/inflammation in CC 228 are more active than those in AC. 229 On the other hand, a large number of CC-specific molecules implicated in antioxidant and/or 230 anti-inflammatory processes were also significantly altered in CC. For example, ENO1, one of the 231 components in the protein biomarker combination, was significantly downregulated in CC cases 232 compared to that in AC cases ( Fig. 3L-M The remarkably elevated level of tryptophan and its downstream product indoleacetaldehyde 243 suggested that AhR activity was more active in CC cases ( Fig. 3N-O) . Furthermore, mannitol has 244 been found to be a hydroxyl radical scavenger that plays important roles in reducing inflammation 34 , 245 and importantly, it was the most significantly upregulated one among all the CC-specific DEMs 246 (Table S12) . Besides, MMA is a dicarboxylic acid that is primarily a by-product of propionate 247 metabolism. Previous study showed that the elevated circulating MMA level caused a significant 248 upregulation of Sex-determining region Y box 4 (SOX4) expression and consequently elicited 249 transcriptional reprogramming 35 , while the role of MMA in regulation of immune response and 250 inflammation is unclear. 251 In addition to the molecules involved in the optimal biomarker combination, we also identified 252 other molecules that contain the potentials to relieve the exacerbated inflammation. For instance, 253 uric acid (UA), an end product of purine catabolism, is a major antioxidant in the blood and can be 254 helpful for protection against free-radical oxidative damage 36 . The plasma level of uric acid in CC 255 cases was 109-folds higher than that in AC cases (Table S12) . 256 Together, our findings indicated that the molecules involved in anti-oxidant and anti-257 inflammation were significantly elevated in the circulating system in CC cases compared with AC 258 cases. Consistent with it, the clinical data showed that the coagulation indicators, such as APTT, 259 PT and D-dimer, the status of immune cell activation, such as the ratios of CD3+CD4+ and 260 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2021. 9 / 33 CD3+CD8+, and the levels of inflammatory factors, such as IFN-γ and IL-1β, in the CC cases were 261 overall normal, albeit some results in certain cases fell outside the normal range (Table 1) (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The infection rate of SARS-CoV-2 to children is similar to that of adults, but the disease of 286 COVID-19 is very mild in most cases of CC. Therefore, better understanding the mechanisms 287 underlying the milder COVID-19 symptom in children has particular importance to uncover the 288 pathogenesis of this disease. For this purpose, we conducted omics study to profile plasma protein 289 and metabolite alterations in CC cases, and identified CC-specific molecule alternations by 290 comparing with the omics data of AC cases. Moreover, we prioritized two optimal biomarker 291 combinations, each of them containing 5 protein biomarkers or 5 metabolite biomarkers, by using 292 the machine learning-based pipeline. These biomarker combinations as well as the individual 293 biomarker in the combinations can accurately distinguish CC group from AC and HC groups. suggest that SARS-CoV-2 replication in CC is restricted by the enhanced levels of COVID-19-317 associated plasma molecules. Correspondingly, we speculated that the immune system of CC is in 318 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2021. a relatively balanced state, in which its activation is stronger than that of AC and is sufficient to 319 restrict SARS-CoV-2 infection and the collateral damages, and meanwhile, the molecules involved 320 in anti-oxidant and anti-inflammation processes are also strongly activated in CC, thereby 321 preventing the exacerbation of inflammation and the deterioration of disease (Fig. 5) . 322 Identification of the alternations of plasma molecules between CC and AC also provides 323 promising therapeutic targets for COVID-19. In this study, we tested the effects of MMA, DHOA, 324 TRP and mannitol on the expression levels of cytokines, as well as the viral replication in MHV-325 infected cells. Interestingly, the changes in the types of cytokine were different in response to 326 distinct metabolite treatments, suggesting that the action to mode of these metabolites are dependent 327 on different cellular signaling pathways. Moreover, we found that MMA or mannitol treatment can 328 efficiently inhibit MHV replication. Mannitol is reported to be a hydroxyl radical scavenger that 329 plays important roles in relieving inflammation 34 . A recent study showed that the SARS-CoV-2 330 infection in monocytes triggers mitochondrial ROS production, which induces stabilization of 331 hypoxia-inducible factor-1α (HIF-1α) and consequently metabolism reprogramming that facilitates 332 the viral replication and inhibits immune responses requires 44 . It is possible that the hydroxyl radical 333 scavenging activity of mannitol relieves the cellular levels of ROS, and in turn suppresses MHV 334 replication. For MMA, its exact role in regulation of immune response or inflammation is not clear. 335 Previous study showed that MMA treatment in A549 cells triggered the induction of SOX4 35 , and 336 interestingly, a recent study found that SOX4 can suppress hepatitis B virus replication via 337 inhibiting hepatocyte nuclear factor 4α 45 . The detailed roles of the identified CC-specific 338 metabolites such as MMA, DHOA and mannitol, require further investigation and the potential 339 therapeutic targets should be further experimentally validated. 340 In summary, our findings provide highly valuable multi-omics data resource for the research 341 community to better understand COVID-19-associated host responses, identify a serial of children-342 specific COVID-19 biomarker candidates, shed lights on the pathogenesis of COVID-19 in children, 343 and provide promising potential therapeutic targets. 344 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2021. The labeling efficiency (calculated from the ratio of number of TMT labeled sites divided by 375 number of all the potential labeling sites) had to pass the threshold of 95% before proceeding to the 376 fractionation step. 377 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The sample was then fractionated into fractions by high pH reverse-phase HPLC using Agilent 378 300Extend C18 column (5 μm particles, 4.6 mm ID, 250 mm length). Briefly, peptides were first 379 separated with a gradient of 2% to 32% acetonitrile in 10 mM ammonium bicarbonate pH 10 over 380 60 min into 60 fractions 46 with an Easy-nLC 1200 system (both Thermo Scientific) 40, 47 . Peptides were loaded onto a home-399 made reversed-phase analytical column (100 μm × 250 mm, 1.9 μm particle size, 120 Å pore size, (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Mobile phase was composed of water containing 0.1% formic acid (A) and acetonitrile containing 429 0.1% formic acid (B). The gradient program initiated from 5% B increased to 90% B in 11.0 min, 430 and held for 1 min and then decreased 5% B for re-equilibrium. 431 The sample extracts of hydrophobic compounds were analyzed using an LC-ESI-MS/MS 432 system (UPLC, Shim-pack UFLC SHIMADZU CBM A system, MS, QTRAP® 6500+ System). 433 The samples were injected onto a Thermo Accucore™ C30 column (2.6 μm, 2.1 mm × 100 mm). 443 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table S16 . Finally, exported all the integral data of chromatographic peak area to save, and used the self-built 474 software package to remove the positive and negative ions of metabolites. We calculated CV values 475 of the metabolites in QC samples, and removed the metabolites whose CV values were larger than 476 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2021. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Using RPA values of the proteomic data and IBA values of the metabolomic data, we 536 identified potential DEPs and DEMs that were significantly altered in CC cases against HC samples. Then, using NAVs of the omic data, we further identified potential DEPs and DEMs that were 538 significantly altered in CC cases against AC cases. The FC value was calculated based on the mean 539 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2021. , (E-ratio > 1) 556 In this study, adjusted P values were calculated using Benjamini & Hochberg correction and 557 only statistically over-represented GO terms for the proteomic data and KEGG pathways for the 558 metabolomic data were considered. GO annotation files (released on 03 January 2020) were 559 downloaded from the Gene Ontology Consortium Web site (http://www.geneontology.org/), and in 560 total we obtained 19,288 human proteins annotated with at least one GO biological process term. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2021. In the step of MDS, mutually identified DEPs or DEMs of CC patients against HC cases and 587 CC cases against AC cases were reserved as a candidate pool. Then, CCG was adopted to select 588 different sets of biomarker combinations with ≤ 5 proteins or metabolites. This number was much 589 smaller than the sample size and could efficiently avoid over-fitting. From the pool, 10,000 590 candidate biomarker combinations were randomly generated for the proteomic and metabolomic 591 data, respectively. The initial weight value of each protein or metabolite was set to 1. 592 In the step of FCP, the 5-fold cross-validation was conducted for model training. For each 593 candidate combination, we randomly generated a training data set and a testing data set with a ratio 594 of approximately 4:1. The testing data set was only used to test the performance but not for training, 595 and the final total AUC value was calculated as below: 596 Total AUC = √AUC CC . HC * AUC CC .AC The least absolute shrinkage and selection operator (LASSO, L1 regularization) penalty and 598 the ridge regression (L2 regularization) penalty in PLR [25] [26] [27] , were iteratively used to optimize the 599 weight values of the 5 proteins or metabolites. To simplify the composition of a combination, one 600 or multiple protein or metabolite was randomly dropped if the total AUC value of the 5-fold cross-601 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2021. ; https://doi.org/10.1101/2021.03.04.21252876 doi: medRxiv preprint 20 / 33 validation was increased. Such a procedure was repeatedly performed until the AUC value was not 602 increased any longer. All biomarker combinations with total AUC equal to 1 were reserved for the 603 proteomic and metabolomic data, respectively (Table S11- (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. respectively. The upper and lower whiskers extend from the hinge to the largest and smallest value 800 no further than 1.5 times the distance between the first and third quartiles, respectively. 801 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2021. ; 33 / 33 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2021. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2021. ; https://doi.org/10.1101/2021.03.04.21252876 doi: medRxiv preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted March 6, 2021. ; https://doi.org/10.1101/2021.03.04.21252876 doi: medRxiv preprint National Health Commission, National Health Commission of the People's Republic of 660 China Median (IQR) WBC CD3+ (cells/μl, normal range 690-2540) CD3+CD4+ (cells/μl, normal range CD3+CD8+ (cells/μl, normal range 190-1140) 482.67 (386.66 APTT (s, normal range PT (s, normal range 11-15)